| JPM US TECHNOLOGY A (DIST) GBP | 29/10 | 92,65% |
| UBS (LUX) GLOBAL QUALITY DIVIDEND EQUITY K-1-ACC | 28/10 | 92,65% |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI A EUR ACC | 29/10 | 92,61% |
| ISHARES MSCI EMU MID CAP UCITS ETF EUR (ACC) | 29/10 | 92,58% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H EUR CAP | 29/10 | 92,55% |
| UBS MSCI CANADA INDEX FUND USD I-W-SSP ACC | 29/10 | 92,55% |
| FIDELITY FUNDS-NORDIC A-ACC-EUR | 29/10 | 92,53% |
| JUPITER MERIAN WORLD EQUITY FUND I EUR CAP | 29/10 | 92,53% |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI A USD ACC | 29/10 | 92,52% |
| INVESCO NASDAQ BIOTECH UCITS ETF ACC | 29/10 | 92,52% |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-EUR | 29/10 | 92,42% |
| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (ACC) | 29/10 | 92,41% |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO IS H EUR CAP | 29/10 | 92,37% |
| ROBECO EMERGING STARS EQUITIES DL EUR | 29/10 | 92,36% |
| M&G (LUX) ASIAN FUND USD C ACC | 29/10 | 92,34% |
| ROBECO EMERGING STARS EQUITIES DL USD | 29/10 | 92,22% |
| ODDO BHF US EQUITY TREND CI-EUR | 29/10 | 92,19% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | 29/10 | 92,17% |
| JPM US TECHNOLOGY A (ACC) EUR (HEDGED) | 29/10 | 92,16% |
| CAJA INGENIEROS IBERIAN EQUITY, FI I | 29/10 | 92,15% |
